Impact of nucleos(t)ide analog treatment on the development of malignancy in patients with chronic hepatitis B

We evaluated whether nucleos(t)ide analog (NA) influences the risk of non-hepatocellular carcinoma (non-HCC) malignancies in patients with chronic hepatitis B (CHB). A total of 9867 patients with CHB were followed up for ≥12 months for the occurrence of any type of malignancy between 1998 and 2013....

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Soon Sun, Ahn, Eun Kyoung, Cho, Soo Yeon, Park, Rae Woong, Cho, Hyo Jung, Kim, Ji-Hyun, Kim, Han Gyeol, Lee, Ga Ram, Hwang, Sun Hyuk, Yang, Min Jae, Cheong, Jae Youn, Cho, Sung Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023687/
https://www.ncbi.nlm.nih.gov/pubmed/29901622
http://dx.doi.org/10.1097/MD.0000000000011087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023687/
https://www.ncbi.nlm.nih.gov/pubmed/29901622
http://dx.doi.org/10.1097/MD.0000000000011087

Ejemplares similares